Canopy Growth’s mixed results stop momentum from recent marijuana-stock rally - MarketWatch
1. Canopy Growth reported a wider-than-expected loss of C$121.9 million. 2. Adult-use cannabis sales fell 10%, impacting overall revenue. 3. Medical cannabis sales increased by 16%, partly offsetting losses. 4. Debt reduced from C$554 million to C$442 million after prepayment. 5. Speculation about U.S. cannabis reform may influence market sentiment.